Healthcare -
Biotechnology - NASDAQ - US
$ 0.326
-1.66 %
$ 3.67 M
Market Cap
-0.01
P/E
Price Target
Average
206.75%
Revenue Forecast
Estimate
555.10%
EBIT
Estimate
68.49%
Net Income
Estimate
30.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cyclacel Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for CYCC of $1 , with forecasts ranging from
a
low of
$1 to a high of $1 .
CYCC Lowest Price Target
Wall Street Target
1 USD
206.75%
CYCC Average Price Target
Wall Street Target
1 USD
206.75%
CYCC Highest Price Target
Wall Street Target
1 USD
206.75%
REVENUE FORECAST
Revenue Forecast Chart CYCC
EBIT FORECAST
EBIT Forecast Chart CYCC
NET INCOME FORECAST
Net Income Chart CYCC